Nvidia was falling as investors expect chips to eventually be targeted for tariffs.

HAUPPAUGE, NY, April 7, 2025 – PRISM MediaWire – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly a premier designer, developer, and manufacturer of advanced signal processing components and systems, reaffirms its commitment to American manufacturing.

LOS ANGELES , April 7, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Constellation Brands, Inc. ("Constellation" or "the Company") (NYSE: STZ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 11, 2024 and January 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 21, 2025.

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

PBI, BJRI and AXTA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 7, 2025.

As a market capitalization-weighted index, the negative changes in the biggest stocks, did the most to drive the overall index lower. We think the S&P 500 still has potentially another 5-7% to fall.

WINTER HAVEN, Fla. , April 7, 2025 /PRNewswire/ -- SouthState announces a group of new hires and promotions in the Private Wealth, Small Business and Commercial Banking divisions.

Berkshire Hathaway (NYSE: BRK.A, BRK.B) has not been immune to the latest wave of stock market turbulence.

Last week's economic landscape was dramatically reshaped by President Trump's announcement of sweeping tariff policies on what he declared “Liberation Day.” His announcement triggered a historic sell-off in the stock market.

The gold market continues to see a lot of forced selling, as traders are trying to cover the overleveraged positions they chose to open in other markets. This being the case, gold will continue to be noisy, as traders have to take this into account, while recognizing that gold is

Just about three years have passed since Capital Group entered the ETF ecosystem. Responding to advisor demand, per head of ETFs Scott Davis, the firm added six core strategies in the ETF wrapper.

LOS ANGELES , April 7, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Semtech Corporation ("Semtech" or "the Company") (NASDAQ: SMTC) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 27, 2024 and February 7, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 21, 2025.

Monday, April 7, 2025 Dear Shareholders and Investors, Non-Executive Vice Chairman of NAT, Alexander Hansson, has today bought 100,000 shares at $2.19 per share. He is now holding 4,400,000 shares.

HOLX's diagnostics strength, robust international potential and new board addition support its "Hold" case. Yet, ongoing global uncertainties remain a drag.